公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 REVVITY DO BRASIL LTDA取消

92 记录

产品持有公司班级有效性
Qsight 210 MD10298910140REVVITY DO BRASIL LTDAII现有
Família de instrumentos chemagic Prime10298910141REVVITY DO BRASIL LTDAI现有
Migele Gel Electrophoresis Unit10298910142REVVITY DO BRASIL LTDAII现有
chemagic DNA CS200 kit10298910143REVVITY DO BRASIL LTDAI现有
NeoBase 2 Succinylacetone Assay Solution Kit10298910145REVVITY DO BRASIL LTDAI现有
NeoBase 2 Non-derivatized Assay Solutions10298910146REVVITY DO BRASIL LTDAI现有
NeoBase 2 Non-derivatized MSMS kit 3044-001010298910147REVVITY DO BRASIL LTDAIII27/07/2030
QSight 225 MD10298910148REVVITY DO BRASIL LTDAII现有
GSP Neo natal Creatine Kinase -MM PN 3311-001010298910151REVVITY DO BRASIL LTDAIII13/10/2030
DELFIA® Xpress sFlt-110298910152REVVITY DO BRASIL LTDAII现有
Eonis DNA EXTRACTION KIT PN 3240-001010298910153REVVITY DO BRASIL LTDAI现有
Chemagic Prime Jr-D10298910154REVVITY DO BRASIL LTDAI现有
Eonis SCID-SMA kit PN 3241-0010/ PN 3242-001010298910155REVVITY DO BRASIL LTDAIII03/05/2031
Família de Reagentes SuperFlex10298910158REVVITY DO BRASIL LTDAI现有
Família de Analisadores SuperFlexTM10298910159REVVITY DO BRASIL LTDAII现有
Família SuperFlex N-terminal Pro-Brain Natriuretic Peptide10298910161REVVITY DO BRASIL LTDAIII15/06/2036
Família SuperFlex All in One C-Reactive Protein10298910162REVVITY DO BRASIL LTDAII现有
Família SuperFlex Procalcitonin10298910163REVVITY DO BRASIL LTDAIII29/06/2036
Família SuperFlex Myoglobin10298910164REVVITY DO BRASIL LTDAIII18/05/2036
EONIS ANALYSIS SOFTWARE PN 5020-100010298910165REVVITY DO BRASIL LTDAII现有
kit PKamp Respiratory SARS-CoV-2 RT-PCR Panel10298910168REVVITY DO BRASIL LTDAIII17/01/2032
GSP® Neonatal Galactose Total kit - PN 3309-002010298910171REVVITY DO BRASIL LTDAIII04/07/2032
SuperFlex IL-610298910172REVVITY DO BRASIL LTDAII现有
Família SuperFlex Cardiac Troponin I10298910173REVVITY DO BRASIL LTDAIII27/03/2033
Família SuperFlex Creatine Kinase-MB10298910174REVVITY DO BRASIL LTDAIII27/03/2033

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家